Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112246 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Chae Eun Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Medicine Inje University, Busan, Republic of Korea. Electronic address: kcr3147@naver.com. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Histone Deacetylase Inhibitors, Indoleamine-Pyrrole 2,3,-Dioxygenase, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
BACKGROUND: A wide array of histone deacetylase (HDAC) inhibitors and aryl hydrocarbon receptor (AHR) agonists commonly arrest experimental autoimmune encephalomyelitis (EAE). However, it is not known whether HDAC inhibition is linked to the AHR signaling pathway in EAE. METHODS: We investigated how the pan-HDAC inhibitor SB939 (pracinostat) exerted immunoregulatory action in the myelin oligodendrocyte glycoprotein 35-55 (MOG35-55)-induced EAE mouse model by evaluating changes in of signal transducer and activator of transcription 3 (STAT3) acetylation and the expression of indoleamine 2,3-dioxygenase 1 (IDO1) and AHR in inflamed spinal cords during EAE evolution. We proved the involvement of IDO1 and the AHR in SB939-mediated immunosuppression using Ido1-/- and Ahr-/- mice. RESULTS: Administration with SB939 halted EAE progression, which depended upon IDO1 expression in neurons of the central nervous system (CNS). Our in vitro and in vivo studies demonstrated that SB939 sustained the interleukin-6-induced acetylation of STAT3, resulting in the stable transcriptional activation of Ido1. The therapeutic effect of SB939 also required the AHR, which is expressed mainly in CD4+ T cells and macrophages in CNS disease lesions. Finally, SB939 was shown to markedly reduce the proliferation of CD4+ T cells in inflamed neuronal tissues but not in the spleen or draining lymph nodes. CONCLUSIONS: Overall, our results suggest that IDO1 tryptophan metabolites produced by neuronal cells may act on AHR in pathogenic CD4+ T cells in a paracrine fashion in the CNS and that the specific induction of IDO1 expression in neurons at disease-afflicted sites can be considered a therapeutic approach to block the progression of multiple sclerosis without affecting systemic immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, College of Medicine Inje University, Busan, Republic of Korea. Electronic address: kcr3147@naver.com.
- Department of Microbiology and Immunology, College of Medicine Inje University, Busan, Republic of Korea. Electronic address: 2sm1983@hanmail.net.
- Department of Microbiology and Immunology, College of Medicine Inje University, Busan, Republic of Korea. Electronic address: dbsdmsgp91@naver.com.
- Department of Microbiology and Immunology, College of Medicine Inje University, Busan, Republic of Korea. Electronic address: gaamza97@hanmail.net.
- Basic and Clinical Convergence Research Institute, University of Ulsan, Ulsan, Republic of Korea. Electronic address: yujin1233420@gmail.com.
- Basic and Clinical Convergence Research Institute, University of Ulsan, Ulsan, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ulsan University Hospital, College of…
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, C. E., Lee, S. M., Yoon, E. H., Won, H. J., Jung, Y. J., Jegal, Y., Kim, D. H., Kwon, B., & Seo, S. K. (2024). Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112246
Vancouver
Kim CE, Lee SM, Yoon EH, Won HJ, Jung YJ, Jegal Y, et al. Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112246
BibTeX
@article{Kim2024,
author = {Kim, Chae Eun and Lee, Soung-Min and Yoon, Eun Hye and Won, Hae Jeong and Jung, Yu Jin and Jegal, Yangjin and Kim, Dong Hyun and Kwon, Byungsuk and Seo, Su-Kil},
title = {Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112246}
}
EUVIMED